Brazilian Hedge Fund Shares Theses for OpenAI Beneficiary and Swiss Botox Alt Maker

There’s little debate that OpenAI is one of the biggest winners in the arms race for artificial intelligence, but a key problem for investors is that the company is privately held. However, there is one way to get exposure to the company via the publicly traded stock market.

In an interview with Hedge Fund Alpha, Andrew Reider and Gustavo Campanha of Sao Paulo, Brazil-based WHG Asset Management shared their bull theses for this OpenAI stock and a Swiss manufacturer of an alternative to Botox.

WHG's first stock...

Login required to continue reading.

Setup a free account to get access to this article (no credit card required).

View Full Article

Already a member? Log in here